NasdaqGS:GHHealthcare
Does Guardant’s 2026 Outlook And Shelf Filing Reshape The Bull Case For Guardant Health (GH)?
In February 2026, Guardant Health reported fourth-quarter 2025 revenue of US$281.27 million and a net loss of US$128.49 million, filed a US$510.17 million shelf registration for 4,795,700 common shares tied to employee stock plans, and issued 2026 revenue guidance of US$1.25–1.28 billion.
Alongside these filings and results, Guardant’s inclusion as a leading contributor in an institutional growth fund and commentary about volume-driven expansion and acquisition activity highlighted growing...